Examining how people with lived experience of neurodegenerative diseases have been included in the development of trustworthy guidelines: a scoping review protocol

OBJECTIVE: This review will examine how people with lived experience of neurodegenerative diseases are being included in the development of trustworthy guidelines. INTRODUCTION: Meaningful inclusion of people with lived experience ensures that guidelines are relevant and implementable; however, people living with neurodegenerative diseases experience progressive cognitive, physical, and communication impairments, which create significant barriers to participation in guideline development. Their involvement is often tokenistic and does not consider the complex challenges associated with neurodegenerative diseases. The findings from this review will be used to develop best-practice principles and standards for their inclusion in guideline development. ELIGIBILITY CRITERIA: This review will include trustworthy published and unpublished guidelines, and their associated methods papers, related to the care or treatment of people (≥18 years of age) with lived experience of neurodegenerative diseases. Eligible guidelines must describe the methods for inclusion of people with lived experience of neurodegenerative diseases. No restrictions will be placed on geographic location or language. METHODS: This review will follow the JBI methodology for scoping reviews and will be reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). Searches will be conducted in MEDLINE (Ovid), CINAHL (EBSCOhost), and Epistemonikos for sources published from 2010 onward. Websites and guideline libraries, including Guidelines International Network and the National Institute for Health and Care Excellence, will be searched for difficult-to-locate and unpublished literature. Two reviewers will independently screen titles, abstracts, and full texts, with attention to equity, diversity, inclusion, and accessibility considerations. The results will be analyzed using frequencies and qualitative content analysis and presented through tables. REVIEW REGISTRATION: OSF https://osf.io/j2ey5/.

Authors

Institutions

Publication Details

Journal
JBI Evidence Synthesis
Published
2026-07-27
DOI
https://doi.org/10.11124/jbies-25-00582
Primary Topic
Mental Health and Patient Involvement
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Examining how people with lived experience of neurodegenerative diseases have been included in the development of trustworthy guidelines: a scoping review protocol

Emma Muhlack, Danielle Pollock, Zachary Munn, Lara Stollery
JBI Evidence Synthesis
Mental Health and Patient Involvement
article

Examining how people with lived experience of neurodegenerative diseases have been included in the development of trustworthy guidelines: a scoping review protocol

Emma Muhlack, Danielle Pollock, Zachary Munn, Lara Stollery
article en

Abstract

OBJECTIVE: This review will examine how people with lived experience of neurodegenerative diseases are being included in the development of trustworthy guidelines. INTRODUCTION: Meaningful inclusion of people with lived experience ensures that guidelines are relevant and implementable; however, people living with neurodegenerative diseases experience progressive cognitive, physical, and communication impairments, which create significant barriers to participation in guideline development. Their involvement is often tokenistic and does not consider the complex challenges associated with neurodegenerative diseases. The findings from this review will be used to develop best-practice principles and standards for their inclusion in guideline development. ELIGIBILITY CRITERIA: This review will include trustworthy published and unpublished guidelines, and their associated methods papers, related to the care or treatment of people (≥18 years of age) with lived experience of neurodegenerative diseases. Eligible guidelines must describe the methods for inclusion of people with lived experience of neurodegenerative diseases. No restrictions will be placed on geographic location or language. METHODS: This review will follow the JBI methodology for scoping reviews and will be reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). Searches will be conducted in MEDLINE (Ovid), CINAHL (EBSCOhost), and Epistemonikos for sources published from 2010 onward. Websites and guideline libraries, including Guidelines International Network and the National Institute for Health and Care Excellence, will be searched for difficult-to-locate and unpublished literature. Two reviewers will independently screen titles, abstracts, and full texts, with attention to equity, diversity, inclusion, and accessibility considerations. The results will be analyzed using frequencies and qualitative content analysis and presented through tables. REVIEW REGISTRATION: OSF https://osf.io/j2ey5/.

JBI Evidence Synthesis
SA Health (AU), The University of Adelaide (AU)
Reduced inequalities
Openalex Percentile: Top 5%
Mental Health and Patient Involvement
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.